
Psiconáutica Editorial Team · November 15, 2026
In brief
- The European Union Drugs Agency (EUDA) presented its first Drug Survey on November 12, 2026, polling 95,883 people aged 15 and older across 35 countries.
- In the EU, 60% consider drug trafficking and use in their area to be serious, and 45% prefer support and assistance over criminal conviction for those who use drugs and encounter the justice system.
- This is an opinion survey: it captures public perceptions and preferences, not actual consumption levels or the efficacy of specific policies.
The Lisbon-based EUDA explains that the survey aims to add the general public’s perspective to its existing epidemiological data and expert assessments. This is the inaugural edition.
Methodology
The agency utilized the European Commission’s Flash Eurobarometer methodology. A total of 95,883 people aged 15 and older were interviewed: 76,766 in the 27 EU member states and 19,117 in Norway, Türkiye, six candidate countries, and Kosovo. Fieldwork took place between June 24 and July 16, 2026, primarily via online and telephone interviews. Headlines focus on the EU-27.
Key findings
Six out of ten people in the EU view drug trafficking and use as serious problems in their local area. The proportion of those who consider drug use in their environment to be serious ranges from 44% in Denmark to 78% in Cyprus. 49% believe that trafficking has increased in their area over the last five years, while 14% believe it has decreased.
Regarding public health concerns, mental health—including psychosis and suicide—leads at 39%, ahead of the harms associated with potent new synthetic drugs (30%). In terms of security, the most cited issue is the involvement of children and adolescents in trafficking (30%). In Spain, as in France, Luxembourg, Malta, and Slovakia, drug-related violence and crime rank first, at 32% in the Spanish case.
Availability and regulation
48% believe they could obtain cannabis within 24 hours, compared to about one-third for cocaine and MDMA. Regarding recreational use, 60% would support banning cocaine and 59% would ban MDMA; for cannabis, 38% would favor a ban, 32% would regulate it, and 16% would leave it without restrictions. When faced with trafficking, the preferred response is to toughen measures against traffickers (39%); legalizing and regulating drugs receives the lowest support (13%).
Support vs. punishment
If someone who uses drugs comes into contact with the justice system, 45% prefer support and assistance, 31% prefer conviction or prison, and 10% prefer a minor sanction. The EUDA emphasizes that this support does not imply social acceptance: only 31% would accept a person who uses drugs as a neighbor.
Limitations
These are perceptions, not measurements: someone viewing a problem as serious in their area does not indicate the actual level of consumption there. Responses depend on the options provided, and the text does not specify how many choices each person could select. The report does not provide details on sampling, weighting, or response rates, and it combines internet and telephone data. The material reviewed contains no data on psychedelics or published results on harm reduction services. The EUDA plans to release further questions and demographic breakdowns in its data explorer in early 2027.
Implications
The survey describes a climate of opinion that is important to understand: notable concern, a preference for help over punishment, and social distance toward those who use drugs. It provides context for the debate but does not prove that any specific policy reduces risks; that requires evaluation data. More on practical approaches can be found in our Psychedelics Guide on harm reduction and responsible use.
Sources
- EUDA, November 12, 2026, press release No. 9/2026: “First EUDA Drug Survey: 6 in 10 in the EU see drug trafficking and drug use as serious problems”.
- EUDA (2026): “EUDA Drug Survey 2026: European attitudes towards drugs and drug policy”. DOI 10.2810/8266522.
Image
Illustrative image: one of the two agency buildings in Lisbon (then EMCDDA). Photo: Carcharoth, via Wikimedia Commons, licensed under CC BY-SA 3.0.
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.